AstraZeneca Dividend
Dividend criteria checks 5/6
AstraZeneca is a dividend paying company with a current yield of 2.06% that is well covered by earnings.
Key information
2.1%
Dividend yield
71%
Payout ratio
Industry average yield | 2.3% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | €4.08 |
Dividend yield forecast in 3Y | 2.2% |
Recent dividend updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: ZEG's dividends per share have been stable in the past 10 years.
Growing Dividend: ZEG's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
AstraZeneca Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (ZEG) | 2.1% |
Market Bottom 25% (DE) | 1.7% |
Market Top 25% (DE) | 4.7% |
Industry Average (Pharmaceuticals) | 2.3% |
Analyst forecast in 3 Years (ZEG) | 2.2% |
Notable Dividend: ZEG's dividend (2.06%) is higher than the bottom 25% of dividend payers in the German market (1.67%).
High Dividend: ZEG's dividend (2.06%) is low compared to the top 25% of dividend payers in the German market (4.7%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (71%), ZEG's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: At its current cash payout ratio (81.6%), ZEG's dividend payments are covered by cash flows.